High blood pressure can lead to liver fibrosis – the gradual stiffening of your liver as thin bands of scar tissue gradually ...

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...

Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.

A research team has identified the transcription factor Lhx2 (LIM homeobox protein 2) as a key regulator in hepatic stellate cells. Lhx2 was found to simultaneously promote liver regeneration and ...

VANCOUVER, Washington, Feb. 06, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential ...

“These viruses can cause cell death, and chronic infections can lead to scarring, or fibrosis,” says Sudha Kodali, MD, a hepatologist in Sugar Land, Texas, and a volunteer for the American ...

Sustained inflammation originating from resident and infiltrating immune cells drives the fibrogenic process during liver injury, and contributes to its resolution, and targeting macrophages is an ...

The paradigm of stellate cell activation provides an important ... The most effective way to eliminate hepatic fibrosis is to clear the primary cause of liver disease. The latter includes ...

Chronic liver disease may predispose to hepatocellular carcinoma, for which therapeutic options are limited. This study aimed to explore the immune cell characteristics of the clinical conditions.